Published in J Neuroimmunol on March 27, 2006
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet (2009) 4.97
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc Natl Acad Sci U S A (2008) 1.27
Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc Natl Acad Sci U S A (2008) 1.04
Constrained mixture estimation for analysis and robust classification of clinical time series. Bioinformatics (2009) 1.00
Systematic review of genome-wide expression studies in multiple sclerosis. BMJ Open (2011) 1.00
Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS One (2010) 0.92
Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks. J Neurol (2008) 0.88
Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis. PLoS One (2011) 0.83
Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS. Neurology (2014) 0.82
Gene expression studies in multiple sclerosis. Curr Genomics (2007) 0.81
Increasing consistency of disease biomarker prediction across datasets. PLoS One (2014) 0.80
Beta-lactam antibiotics modulate T-cell functions and gene expression via covalent binding to cellular albumin. Proc Natl Acad Sci U S A (2013) 0.78
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells. J Neuroimmunol (2012) 0.76
Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects. Front Cell Neurosci (2015) 0.75
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med (2002) 4.34
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci U S A (2005) 2.83
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med (2007) 2.64
Thyrotrophin in the pars tuberalis triggers photoperiodic response. Nature (2008) 2.60
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology (2004) 2.54
c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol (2004) 2.46
Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol (2009) 2.42
The regulatory role of natural killer cells in multiple sclerosis. Brain (2004) 1.84
Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J Immunol (2007) 1.77
Circadian clock gene regulation of steroidogenic acute regulatory protein gene expression in preovulatory ovarian follicles. Endocrinology (2007) 1.74
Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum (2004) 1.74
Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan. Amyotroph Lateral Scler (2006) 1.73
Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol (2006) 1.72
Narrowing candidate region for monosomy 9p syndrome to a 4.7-Mb segment at 9p22.2-p23. Am J Med Genet A (2006) 1.70
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med (2007) 1.69
Light-induced hormone conversion of T4 to T3 regulates photoperiodic response of gonads in birds. Nature (2003) 1.67
Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J Immunol (2007) 1.67
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology (2014) 1.62
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest (2004) 1.61
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest (2010) 1.60
Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. J Gastroenterol Hepatol (2007) 1.60
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci U S A (2011) 1.60
Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int (2008) 1.54
"OSMS is NMO, but not MS": confirmed by NMO-IgG? Lancet Neurol (2005) 1.54
Blood-brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study. J Neurol Neurosurg Psychiatry (2013) 1.53
p250GAP, a novel brain-enriched GTPase-activating protein for Rho family GTPases, is involved in the N-methyl-d-aspartate receptor signaling. Mol Biol Cell (2003) 1.48
A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol (2004) 1.46
Flagellate erythema. Int J Dermatol (2006) 1.45
Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol (2005) 1.45
Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier. J Neurol Neurosurg Psychiatry (2013) 1.45
Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication. J Hum Genet (2012) 1.45
Hodgkin's disease-related central nervous system angiopathy presenting as reversible posterior leukoencephalopathy. Intern Med (2004) 1.42
Prediction of the surgical difficulty of single-port laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech (2012) 1.42
Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci U S A (2002) 1.40
Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol (2004) 1.40
Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategies. Immunotherapy (2009) 1.39
Pyoderma gangrenosum following surgical procedures. Int J Dermatol (2010) 1.38
Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected]. J Immunol (2003) 1.38
NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol (2008) 1.35
Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. J Immunol (2008) 1.34
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol (2011) 1.33
STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome--result of Japanese cohort study. Epilepsia (2010) 1.30
Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. JAMA Neurol (2013) 1.30
Depletion of mammalian CCR4b deadenylase triggers elevation of the p27Kip1 mRNA level and impairs cell growth. Mol Cell Biol (2007) 1.29
Natural killer T cells accelerate atherogenesis in mice. Blood (2004) 1.28
Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma. J Invest Dermatol (2003) 1.26
Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol (2008) 1.26
CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol (2003) 1.25
Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology (2009) 1.23
Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol (2003) 1.21
Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery (2006) 1.20
Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis (2005) 1.20
Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol (2004) 1.20
Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol (2011) 1.19
Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. Am J Med Genet A (2004) 1.19
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Mod Rheumatol (2012) 1.17
An extramural gastrointestinal stromal tumor of the duodenum mimicking a pancreatic head tumor. J Hepatobiliary Pancreat Surg (2005) 1.16
Niemann-Pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity. Ann Neurol (2002) 1.16
Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol (2007) 1.16
Human astrocytes express aquaporin-1 and aquaporin-4 in vitro and in vivo. Neuropathology (2007) 1.14
A familial 593-kb microdeletion of 16p11.2 associated with mental retardation and hemivertebrae. Eur J Med Genet (2009) 1.12
Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol (2007) 1.12
IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood (2005) 1.12